Table of Content

1 STUDY COVERAGE 1
1.1 Prothrombin Complex Concentrate (PCC) Drug Product Introduction 1
1.2 Market by Type 1
1.2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2034 1
1.2.2 Cofact 4
1.2.3 Beriplex 5
1.2.4 Profilnine 6
1.2.5 Octaplex 7
1.2.6 Prothromplex 8
1.3 Market by Application 8
1.3.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2034 9
1.3.2 Hemophilia B 11
1.3.3 Acquired Coagulation Factor Deficiency 12
1.4 Study Objectives 12
1.5 Years Considered 13
2 EXECUTIVE SUMMARY 14
2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Estimates and Forecasts 2017-2034 14
2.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Estimates and Forecasts 2017-2034 15
2.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2017 VS 2021 VS 2034 17
2.4 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Country 18
2.4.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2024) 18
2.4.2 Europe and United States Sales Prothrombin Complex Concentrate (PCC) Drug by Country (2023-2034) 20
2.5 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country 22
2.5.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2024) 22
2.5.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2023-2034) 23
2.6 Germany 24
2.7 France 25
2.8 UK 26
2.9 Italy 27
2.10 Spain 28
2.11 Netherland 29
2.12 United States 30
2.13 Other Countries 31
3 COMPETITION BY MANUFACTURERS 33
3.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Manufacturers 33
3.1.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Manufacturers (2017-2024) 33
3.1.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Manufacturers (2017-2024) 34
3.1.3 Europe and United States Top Largest Manufacturers of Prothrombin Complex Concentrate (PCC) Drug in 2021 34
3.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Manufacturers 35
3.2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Manufacturers (2017-2024) 35
3.2.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Manufacturers (2017-2024) 36
3.2.3 Europe and United States Top Companies by Prothrombin Complex Concentrate (PCC) Drug Revenue in 2021 36
3.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Price by Manufacturers (2017-2024) 37
3.4 Analysis of Competitive Landscape 38
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 38
3.4.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug by Company Type (Tier 1, Tier 2, and Tier 3) 39
3.4.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Manufacturers Geographical Distribution 39
3.5 Mergers & Acquisitions, Expansion Plans 41
4 MARKET SIZE BY TYPE 43
4.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Type 43
4.1.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Historical Sales by Type (2017-2024) 43
4.1.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Forecasted Sales by Type (2023-2034) 43
4.1.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2034) 44
4.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Type 45
4.2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Historical Revenue by Type (2017-2024) 45
4.2.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Forecasted Revenue by Type (2023-2034) 46
4.2.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2034) 46
4.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price by Type 48
4.3.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price by Type (2017-2024) 48
4.3.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price Forecast by Type (2023-2034) 48
5 MARKET SIZE BY APPLICATION 50
5.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Application 50
5.1.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Historical Sales by Application (2017-2024) 50
5.1.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Forecasted Sales by Application (2023-2034) 50
5.1.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2034) 51
5.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Application 52
5.2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Historical Revenue by Application (2017-2024) 52
5.2.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Forecasted Revenue by Application (2023-2034) 53
5.2.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2034) 53
5.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price by Application 54
5.3.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price by Application (2017-2024) 54
5.3.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price Forecast by Application (2023-2034) 55
6 GERMANY 56
6.1 Germany Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 56
6.1.1 Germany Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2034) 56
6.1.2 Germany Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2034) 57
6.2 Germany Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 59
6.2.1 Germany Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2034) 59
6.2.2 Germany Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2034) 60
7 FRANCE 62
7.1 France Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 62
7.1.1 France Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2034) 62
7.1.2 France Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2034) 63
7.2 France Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 65
7.2.1 France Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2034) 65
7.2.2 France Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2034) 66
8 UK 68
8.1 UK Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 68
8.1.1 UK Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2034) 68
8.1.2 UK Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2034) 69
8.2 UK Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 71
8.2.1 UK Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2034) 71
8.2.2 UK Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2034) 72
9 ITALY 74
9.1 Italy Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 74
9.1.1 Italy Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2034) 74
9.1.2 Italy Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2034) 75
9.2 Italy Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 77
9.2.1 Italy Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2034) 77
9.2.2 Italy Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2034) 78
10 SPAIN 80
10.1 Spain Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 80
10.1.1 Spain Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2034) 80
10.1.2 Spain Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2034) 81
10.2 Spain Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 83
10.2.1 Spain Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2034) 83
10.2.2 Spain Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2034) 84
11 NETHERLAND 86
11.1 Netherland Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 86
11.1.1 Netherland Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2034) 86
11.1.2 Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2034) 87
11.2 Netherland Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 89
11.2.1 Netherland Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2034) 89
11.2.2 Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2034) 90
12 UNITED STATES 92
12.1 United States Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 92
12.1.1 United States Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2034) 92
12.1.2 United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2034) 93
12.2 United States Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 95
12.2.1 United States Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2034) 95
12.2.2 United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2034) 96
13 OTHER COUNTRIES 98
13.1 Other Countries Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 98
13.1.1 Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2034) 98
13.1.2 Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2034) 99
13.2 Other Countries Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 101
13.2.1 Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2034) 101
13.2.2 Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2034) 102
14 CORPORATE PROFILE 104
14.1 CSL Behring 104
14.1.1 CSL Behring Corporation Information 104
14.1.2 CSL Behring Overview 105
14.1.3 CSL Behring in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2024) 105
14.1.4 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 106
14.1.5 CSL Behring Recent Developments 107
14.2 Grifols 108
14.2.1 Grifols Corporation Information 108
14.2.2 Grifols Overview 108
14.2.3 Grifols in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2024) 109
14.2.4 Grifols Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 109
14.2.5 Grifols Recent Developments 110
14.3 Octapharma 111
14.3.1 Octapharma Corporation Information 111
14.3.2 Octapharma Overview 111
14.3.3 Octapharma in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2024) 112
14.3.4 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 112
14.3.5 Octapharma Recent Developments 113
14.4 Prothya Biosolutions 114
14.4.1 Prothya Biosolutions Corporation Information 114
14.4.2 Prothya Biosolutions Overview 115
14.4.3 Prothya Biosolutions in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2024) 116
14.4.4 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 116
14.5 Takeda 117
14.5.1 Takeda Corporation Information 117
14.5.2 Takeda Overview 118
14.5.3 Takeda in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2024) 118
14.5.4 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 119
14.5.5 Takeda Recent Developments 119
15 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 121
15.1 Prothrombin Complex Concentrate (PCC) Drug Industry Chain Analysis 121
15.2 Prothrombin Complex Concentrate (PCC) Drug Key Raw Materials 122
15.2.1 Key Raw Materials 122
15.2.2 Raw Materials Key Suppliers 123
15.3 Prothrombin Complex Concentrate (PCC) Drug Production Mode & Process 124
15.4 Prothrombin Complex Concentrate (PCC) Drug Sales and Marketing 126
15.4.1 Prothrombin Complex Concentrate (PCC) Drug Sales Channels 126
15.4.2 Prothrombin Complex Concentrate (PCC) Drug Distributors 127
15.5 Prothrombin Complex Concentrate (PCC) Drug Customers 130
16 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET DYNAMICS 133
16.1.1 Prothrombin Complex Concentrate (PCC) Drug Industry Trends 133
16.1.2 Prothrombin Complex Concentrate (PCC) Drug Market Drivers 136
16.1.3 Prothrombin Complex Concentrate (PCC) Drug Market Challenges 137
16.1.4 Prothrombin Complex Concentrate (PCC) Drug Market Restraints 138
17 KEY FINDINGS IN THE EUROPE AND UNITED STATES PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG STUDY 139
18 APPENDIX 141
18.1 Research Methodology 141
18.1.1 Methodology/Research Approach 141
18.1.2 Data Source 145
18.2 Author Details 149
18.3 Disclaimer 149

List of Figure

Table 1. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2034 (US$ Million) 2
Table 2. Major Manufacturers of Beriplex 6
Table 3. Major Manufacturers of Profilnine 7
Table 4. Major Manufacturers of Octaplex 7
Table 5. Major Manufacturers of Prothromplex 8
Table 6. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2034 (US$ Million) 9
Table 7. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2017 VS 2021 VS 2034 (US$ Million) 17
Table 8. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2024) & (K Units) 18
Table 9. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2017-2024) 19
Table 10. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2023-2034) & (K Units) 20
Table 11. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2023-2034) 21
Table 12. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2024) & (US$ Million) 22
Table 13. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2017-2024) 22
Table 14. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2023-2034) & (US$ Million) 23
Table 15. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2023-2034) 23
Table 16. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Manufacturers (2017-2024) & (K Units) 33
Table 17. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Share by Manufacturers (2017-2024) 34
Table 18. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Manufacturers (2017-2024) & (US$ Million) 35
Table 19. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Manufacturers (2017-2024) 36
Table 20. Prothrombin Complex Concentrate (PCC) Drug Price by Manufacturers (2017-2024) & (US$/Unit) 37
Table 21. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Manufacturers Market Concentration Ratio (CR5 and HHI) 38
Table 22. Europe and United States Prothrombin Complex Concentrate (PCC) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prothrombin Complex Concentrate (PCC) Drug as of 2021) 39
Table 23. Prothrombin Complex Concentrate (PCC) Drug Manufacturing Base Distribution and Headquarters 40
Table 24. Manufacturers Prothrombin Complex Concentrate (PCC) Drug Product Offered 40
Table 25. Founded Date of Prothrombin Complex Concentrate (PCC) Drug Manufacturer 40
Table 26. Mergers & Acquisitions, Expansion Plans 41
Table 27. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2024) & (K Units) 43
Table 28. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2034) & (K Units) 43
Table 29. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Share by Type (2017-2024) 44
Table 30. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Share by Type (2023-2034) 44
Table 31. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2024) & (US$ Million) 45
Table 32. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2034) & (US$ Million) 46
Table 33. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Type (2017-2024) 46
Table 34. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Type (2023-2034) 47
Table 35. Prothrombin Complex Concentrate (PCC) Drug Price by Type (2017-2024) & (US$/Unit) 48
Table 36. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price Forecast by Type (2023-2034) & (US$/Unit) 48
Table 37. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2024) & (K Units) 50
Table 38. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2034) & (K Units) 50
Table 39. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Share by Application (2017-2024) 51
Table 40. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Share by Application (2023-2034) 51
Table 41. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2024) & (US$ Million) 52
Table 42. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2034) & (US$ Million) 53
Table 43. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Application (2017-2024) 53
Table 44. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Application (2023-2034) 53
Table 45. Prothrombin Complex Concentrate (PCC) Drug Price by Application (2017-2024) & (US$/Unit) 54
Table 46. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price Forecast by Application (2023-2034) & (US$/Unit) 55
Table 47. Germany Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2024) & (K Units) 56
Table 48. Germany Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2034) & (K Units) 56
Table 49. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2024) & (US$ Million) 57
Table 50. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2034) & (US$ Million) 58
Table 51. Germany Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2024) & (K Units) 59
Table 52. Germany Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2034) & (K Units) 59
Table 53. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2024) & (US$ Million) 60
Table 54. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2034) & (US$ Million) 61
Table 55. France Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2024) & (K Units) 62
Table 56. France Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2034) & (K Units) 62
Table 57. France Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2024) & (US$ Million) 63
Table 58. France Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2034) & (US$ Million) 63
Table 59. France Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2024) & (K Units) 65
Table 60. France Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2034) & (K Units) 65
Table 61. France Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2024) & (US$ Million) 66
Table 62. France Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2034) & (US$ Million) 67
Table 63. UK Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2024) & (K Units) 68
Table 64. UK Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2034) & (K Units) 68
Table 65. UK Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2024) & (US$ Million) 69
Table 66. UK Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2034) & (US$ Million) 70
Table 67. UK Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2024) & (K Units) 71
Table 68. UK Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2034) & (K Units) 71
Table 69. UK Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2024) & (US$ Million) 72
Table 70. UK Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2034) & (US$ Million) 73
Table 71. Italy Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2024) & (K Units) 74
Table 72. Italy Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2034) & (K Units) 74
Table 73. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2024) & (US$ Million) 75
Table 74. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2034) & (US$ Million) 76
Table 75. Italy Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2024) & (K Units) 77
Table 76. Italy Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2034) & (K Units) 77
Table 77. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2024) & (US$ Million) 78
Table 78. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2034) & (US$ Million) 79
Table 79. Spain Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2024) & (K Units) 80
Table 80. Spain Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2034) & (K Units) 80
Table 81. Spain Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2024) & (US$ Million) 81
Table 82. Spain Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2034) & (US$ Million) 82
Table 83. Spain Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2024) & (K Units) 83
Table 84. Spain Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2034) & (K Units) 83
Table 85. Spain Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2024) & (US$ Million) 84
Table 86. Spain Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2034) & (US$ Million) 85
Table 87. Netherland Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2024) & (K Units) 86
Table 88. Netherland Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2034) & (K Units) 86
Table 89. Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2024) & (US$ Million) 87
Table 90. Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2034) & (US$ Million) 88
Table 91. Netherland Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2024) & (K Units) 89
Table 92. Netherland Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2034) & (K Units) 89
Table 93. Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2024) & (US$ Million) 90
Table 94. Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2034) & (US$ Million) 91
Table 95. United States Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2024) & (K Units) 92
Table 96. United States Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2034) & (K Units) 92
Table 97. United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2024) & (US$ Million) 93
Table 98. United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2034) & (US$ Million) 93
Table 99. United States Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2024) & (K Units) 95
Table 100. United States Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2034) & (K Units) 95
Table 101. United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2024) & (US$ Million) 96
Table 102. United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2034) & (US$ Million) 97
Table 103. Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2024) & (K Units) 98
Table 104. Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2034) & (K Units) 98
Table 105. Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2024) & (US$ Million) 99
Table 106. Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2034) & (US$ Million) 100
Table 107. Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2024) & (K Units) 101
Table 108. Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2034) & (K Units) 101
Table 109. Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2024) & (US$ Million) 102
Table 110. Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2034) & (US$ Million) 103
Table 111. CSL Behring Corporation Information 104
Table 112. CSL Behring Description and Major Businesses 105
Table 113. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2024) 105
Table 114. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 106
Table 115. CSL Behring Recent Developments 107
Table 116. Grifols Corporation Information 108
Table 117. Grifols Description and Major Businesses 108
Table 118. Grifols Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2024) 109
Table 119. Grifols Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 109
Table 120. Grifols Recent Developments 110
Table 121. Octapharma Corporation Information 111
Table 122. Octapharma Description and Major Businesses 111
Table 123. Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2024) 112
Table 124. Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 112
Table 125. Octapharma Recent Developments 113
Table 126. Prothya Biosolutions Corporation Information 114
Table 127. Prothya Biosolutions Description and Major Businesses 115
Table 128. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2024) 116
Table 129. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 116
Table 130. Takeda Corporation Information 117
Table 131. Takeda Description and Major Businesses 118
Table 132. Takeda Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2024) 118
Table 133. Takeda Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 119
Table 134. Takeda Recent Developments 119
Table 135. Key Raw Materials Lists 122
Table 136. Plasma: Cost Components 122
Table 137. Raw Materials Key Suppliers Lists 123
Table 138. Prothrombin Complex Concentrate (PCC) Drug Distributors List 127
Table 139. Prothrombin Complex Concentrate (PCC) Drug Customers List 130
Table 140. Prothrombin Complex Concentrate (PCC) Drug Market Trends 133
Table 141. Key Transactions in the Blood Plasma Fractionation Industry 1997鈥2019 (Market Trends) 133
Table 142. Prothrombin Complex Concentrate (PCC) Drug Market Drivers 136
Table 143. Prothrombin Complex Concentrate (PCC) Drug Market Challenges 137
Table 144. Prothrombin Complex Concentrate (PCC) Drug Market Restraints 138
Table 145. Research Programs/Design for This Report 141
Table 146. Key Data Information from Secondary Sources 146
Table 147. Key Data Information from Primary Sources 147



List of Figures

Figure 1. Prothrombin Complex Concentrate (PCC) Drug Product Picture 1
Figure 2. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Size Growth Rate by Type, 2017-2034 (US$ Million) 2
Figure 3. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Share by Type: 2021 3
Figure 4. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Share by Type: 2034 4
Figure 5. Cofact Product Picture 5
Figure 6. Major Manufacturers of Cofact 5
Figure 7. Beriplex Product Picture 6
Figure 8. Profilnine Product Picture 6
Figure 9. Octaplex Product Picture 7
Figure 10. Prothromplex Product Picture 8
Figure 11. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Size Growth Rate by Application, 2017-2034 (US$ Million) 9
Figure 12. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Share by Application: 2021 10
Figure 13. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Share by Application: 2034 11
Figure 14. Hemophilia B 12
Figure 15. Prothrombin Complex Concentrate (PCC) Drug Report Years Considered 13
Figure 16. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales 2017-2034 (K Units) 15
Figure 17. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue, (US$ Million), 2017 VS 2024 VS 2034 16
Figure 18. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue 2017-2034 (US$ Million) 16
Figure 19. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country in Percentage: 2021 17
Figure 20. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country in Percentage: 2034 18
Figure 21. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2017-2024) 20
Figure 22. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2023-2034) 21
Figure 23. Germany Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2034) & (K Units) 24
Figure 24. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2034) & (US$ Million) 25
Figure 25. France Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2034) & (K Units) 25
Figure 26. France Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2034) & (US$ Million) 26
Figure 27. UK Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2034) & (K Units) 26
Figure 28. UK Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2034) & (US$ Million) 27
Figure 29. Italy Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2034) & (K Units) 27
Figure 30. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2034) & (US$ Million) 28
Figure 31. Spain Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2034) & (K Units) 28
Figure 32. Spain Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2034) & (US$ Million) 29
Figure 33. Netherland Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2034) & (K Units) 29
Figure 34. Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2034) & (US$ Million) 30
Figure 35. United States Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2034) & (K Units) 30
Figure 36. United States Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2034) & (US$ Million) 31
Figure 37. Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2034) & (K Units) 31
Figure 38. Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2034) & (US$ Million) 32
Figure 39. The Prothrombin Complex Concentrate (PCC) Drug Market Share of Top Largest Manufacturers in Europe and United States in 2021 35
Figure 40. The Top Largest Manufacturers of Prothrombin Complex Concentrate (PCC) Drug in Europe and United States: Market Share by Prothrombin Complex Concentrate (PCC) Drug Revenue in 2021 37
Figure 41. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2034) 45
Figure 42. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2034) 47
Figure 43. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2034) 52
Figure 44. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2034) 54
Figure 45. Germany Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2034) 57
Figure 46. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2034) 58
Figure 47. Germany Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2034) 60
Figure 48. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2034) 61
Figure 49. France Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2034) 63
Figure 50. France Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2034) 64
Figure 51. France Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2034) 66
Figure 52. France Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2034) 67
Figure 53. UK Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2034) 69
Figure 54. UK Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2034) 70
Figure 55. UK Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2034) 72
Figure 56. UK Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2034) 73
Figure 57. Italy Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2034) 75
Figure 58. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2034) 76
Figure 59. Italy Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2034) 78
Figure 60. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2034) 79
Figure 61. Spain Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2034) 81
Figure 62. Spain Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2034) 82
Figure 63. Spain Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2034) 84
Figure 64. Spain Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2034) 85
Figure 65. Netherland Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2034) 87
Figure 66. Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2034) 88
Figure 67. Netherland Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2034) 90
Figure 68. Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2034) 91
Figure 69. United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2034) 93
Figure 70. United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2034) 94
Figure 71. United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2034) 96
Figure 72. United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2034) 97
Figure 73. Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2034) 99
Figure 74. Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2034) 100
Figure 75. Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2034) 102
Figure 76. Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2034) 103
Figure 77. Prothrombin Complex Concentrate (PCC) Drug Value Chain 121
Figure 78. Diagram of Automated Plasma Collection Procedure 123
Figure 79. Manufacturing Process Analysis of Blood Plasma Fractionation 124
Figure 80. Main Product Separation Sequence of Blood Products during the Separation Process 125
Figure 81. Manufacturing Process Analysis of Prothrombin Complex Concentrate (PCC) Drug 125
Figure 82. Channels of Distribution 126
Figure 83. Distributors Profiles 129
Figure 84. Bottom-up and Top-down Approaches for This Report 144
Figure 85. Data Triangulation 145
Figure 86. Key Executives Interviewed 148